Title of latest blog
30 November -1
The appearance of artemisinin-resistant Plasmodium falciparum malaria in the Greater Mekong sub-region is a major threat to global health security, and would have a significant economic impact that may seriously undermine years of malaria investment, says Dr Tim France from the Asia Pacific Leaders Malaria Alliance in “The Roll Back Malaria (RBM) Partnership World Malaria Day blog series”.
This blog is part of the #DefeatMalaria World Malaria Day blog series hosted by Roll Back Malaria, to be published between April 8 and May 1, 2015
Across the endemic world the recommended first-line treatment for uncomplicated falciparum malaria is artemisinin-based combination therapy (ACT). Large recent investments have extended its coverage substantially, helping to drive down malaria deaths.
However, artemisinin-resistant Plasmodium falciparum malaria has emerged on the Cambodia/Thailand border and has recently been detected as far west as the Myanmar/India border. The situation is worryingly reminiscent of previous emergence of resistance to chloroquine, sulfadoxine–pyrimethamine and mefloquine. Artemisinin resistance is a major threat to health security, with the most severe potential effects in sub-Saharan Africa, where the disease burden is highest and systems for monitoring and containment of resistance are inadequate.
Image credit
Other articles from the Roll Back Malaria (RBM) Partnership #DefeatMalaria (link to https://twitter.com/search?q=%23defeatmalaria&src=typd) World Malaria Day blog series
In heading 3, copy title from previous blog
In normal "paragraph" font, copy 2 first paragraphs of the blog
- Read the full blog post from Dr xxx (add hyperlink to this whole line)
In heading 3, copy title from previous blog
In normal "paragraph" font, copy 2 first paragraphs of the blog
- Read the full blog post from Dr xxx (add hyperlink to this whole line)
etc